{"id":448645,"title":"Guidance Document Alternate Sample Retention Site Guidelines (GUI-0014) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T17:23:47.699000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/alternate-sample-retention-site-guidelines-0014.html?wbdisable=false","snippet":"Guidance Document Alternate Sample Retention Site Guidelines (GUI-0014) This guidance has been archived. Updated content for GUI-0014 is included in: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) . This HTML document is not a…","rawSnapshotUrl":"/api/snapshots/raw/448645","browseUrl":"https://replay.healtharchive.ca/job-6/20260103172347/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/alternate-sample-retention-site-guidelines-0014.html?wbdisable=false#ha_snapshot=448645","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}